Cargando…

Resistance of rheumatoid arthritis synovial fibroblasts to p38 MAP-kinase inhibition of pro-destructive functions mediated by tumor necrosis factor alpha/tumor necrosis factor receptor-1

Detalles Bibliográficos
Autores principales:	Kunisch, E, Ukena, B, Fuhrmann, R, Roth, A, Winter, R, Kinne, RW
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834114/ http://dx.doi.org/10.1186/ar1636

Ejemplares similares

Differential influence of IL-1-β, TNF-α, and PDGF-BB on the expression of matrix-metalloproteinases (MMPs) and 'total'-MMP activity in early-passage RA- and OA-synovial fibroblasts (SFB)
por: Kinne, RW, et al.
Publicado: (2002)

Salivary tumor necrosis factor-α and periodontal destruction
por: Tin, Sim Sai, et al.
Publicado: (2015)

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
por: Mukaro, Violet R., et al.
Publicado: (2018)

Laminin, but not lipopolysaccharide, IL-1 or tumor necrosis factor alpha, induces IL-16 gene activity in synovial fibroblasts
por: Aicher, W, et al.
Publicado: (2003)

Methotrexate, through adenosine release, downregulates tumor necrosis factor alpha-induced synovial fibroblast IL-15 expression and proliferation
por: Miranda, E, et al.
Publicado: (2005)

Increased Autophagy Enhances the Resistance to Tumor Necrosis Factor-Alpha Treatment in Rheumatoid Arthritis Human Fibroblast-Like Synovial Cell
por: Dai, Yujie, et al.
Publicado: (2018)

Discrepancy between jun/fos proto-oncogene mRNA and protein expression in the rheumatoid arthritis synovial membrane
por: Huber, R, et al.
Publicado: (2005)

IL-33 regulates TNF-α dependent effects in synovial fibroblasts
por: KUNISCH, ELKE, et al.
Publicado: (2012)

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts
Publicado: (1985)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor
Publicado: (1986)

Effects of sesamin on primary human synovial fibroblasts and SW982 cell line induced by tumor necrosis factor-alpha as a synovitis-like model
por: Khansai, Manatsanan, et al.
Publicado: (2017)

Tumor Necrosis Factor and Splenectomy
por: Yavaşoğlu, İrfan
Publicado: (2016)

The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts
por: Mattyasovszky, Stefan G, et al.
Publicado: (2010)

Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2
por: Miao, Kun, et al.
Publicado: (2020)

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)

TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH ALOPECIA AREATA
por: Kasumagic-Halilovic, Emina, et al.
Publicado: (2011)

Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
por: Agarwal, Renu, et al.
Publicado: (2012)

Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
por: Tseng, Wei-Cheng, et al.
Publicado: (2023)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

Differential Effects of Inhibitor Combinations on Lysophosphatidic Acid-Mediated Chemokine Secretion in Unprimed and Tumor Necrosis Factor-α-Primed Synovial Fibroblasts
por: Hui, Weili, et al.
Publicado: (2017)

Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis
por: Kawabata, Tomoko, et al.
Publicado: (2010)

Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
por: Özler, Kenan, et al.
Publicado: (2016)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint
por: Fiocco, Ugo, et al.
Publicado: (2010)

Inflammation, tumor necrosis factor, and toxicology.
por: Luster, M I
Publicado: (1998)

Tumor Necrosis Factor and Regulatory T Cells
por: Jung, Min Kyung, et al.
Publicado: (2019)

Tumor necrosis factor and interferon: cytokines in harmony
por: Bartee, Eric, et al.
Publicado: (2008)

The role of tumor necrosis factor-alpha in systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2008)

Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality
Publicado: (1994)

Systemic use of tumor necrosis factor alpha as an anticancer agent
por: Roberts, Nicholas J., et al.
Publicado: (2011)

Post-transcriptional regulation of tumor necrosis factor alpha expression
por: Brooks, S, et al.
Publicado: (2004)

Tumor Necrosis Factor-Alpha Polymorphism at Position -238 in Preeclampsia
por: Naderi, Mohammad, et al.
Publicado: (2014)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Evaluation of Tumor Necrosis Factor Alpha Polymorphism Frequencies in Endometriosis
por: Abutorabi, Roshanak, et al.
Publicado: (2015)

Alopecia secondary to anti-tumor necrosis factor-alpha therapy()
por: Ribeiro, Lara Beatriz Prata, et al.
Publicado: (2015)

Tumor Necrosis Factor Alpha Inhibitor-Induced Acute Pancreatitis
por: Werlang, Monia E., et al.
Publicado: (2017)

Tumor necrosis factor alpha mediates neuromuscular synapse elimination
por: Fu, Xiu-Qing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gkindg9qpqjprpftgfd4fid7eb